Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Colleen L. Overley"'
Autor:
Madeline Fuller, Elizabeth B. Autry, Tyler E. Bosley, Robert J. Kuhn, Colleen L. Overley, Brian Gardner
Publikováno v:
J Pediatr Pharmacol Ther
OBJECTIVE Vancomycin dosing requirements to achieve a target area under curve/minimum inhibitory concentration (AUC/MIC) of 400 to 600 mg•hr/L have not been established in pediatrics. Dose modeling studies and recent guidelines suggest dosing highe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33cf98407791b2559f61ccbfeaa0fdd3
https://doi.org/10.5863/1551-6776-26.7.746
https://doi.org/10.5863/1551-6776-26.7.746
Publikováno v:
Journal of Oncology Pharmacy Practice. 27:1963-1981
Objective Oral anticancer therapies have demonstrated superior outcomes compared to traditional cytotoxic chemotherapy in many disease states. However, certain patients may not be candidates for these agents due to odynphagia or dysphagia. The purpos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9a6d7557560975ccd76319f94963317
https://doi.org/10.1177/10781552211037976
https://doi.org/10.1177/10781552211037976
Autor:
Joan M. Stachnik, Colleen L. Overley, Michael Gabay, Katie E. Long, Linda R. Bressler, John L. Villano, Scott Wirth
Publikováno v:
CNS drugs. 29(11)
The purpose of our review is to summarize the clinical activity of oral targeted agents against brain metastases. This includes BRAF inhibitors (dabrafenib and vemurafenib), human epidermal growth factor receptor inhibitors (lapatinib, gefitinib, erl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c52ad23f17d25e5e2de04df216537cdc
https://pubmed.ncbi.nlm.nih.gov/26563196
https://pubmed.ncbi.nlm.nih.gov/26563196